Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AGX808 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8)

This E. coli recombinant protein 2019-nCoV Nucleocaspid Recombinant Antigen,full length (Ag-8), Cat. No. AGX808 is tested for use in Lateral Flow Assay.

AGX808
1 mg  
Purchase on Sigma-Aldrich

概述

Replacement Information
Description
Catalogue NumberAGX808
Description2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8)
Alternate Names
  • SARS-CoV
  • SARS-CoV-2
Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
References
Product Information
FormatPurified
PresentationPurified protein in 10 mM Phosphate buffer, 150 mM NaCl with no preservatives, pH 7.4.
Quality LevelMQ100
Applications
ApplicationThis E. coli recombinant protein 2019-nCoV Nucleocaspid Recombinant Antigen,full length (Ag-8), Cat. No. AGX808 is tested for use in Lateral Flow Assay.
Key Applications
  • Immunodiffusion
Application NotesOther recommended antigen products for lateral flow application are AGX804 or AGX806.
Biological Information
CloneN/A
ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
SpecificitySARS CoV-2
Purification MethodColumn Purification
UniProt Number
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size1 mg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
AGX808 04061842457854

Documentation

2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) MSDS

职位

物料安全数据表 (MSDS) 

2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) 分析证书

标题批号
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3574427 3574427
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3616501 3616501
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3693110 3693110
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3780591 3780591
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3808747 3808747
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3870086 3870086
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3887110 3887110
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 3932139 3932139
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 4015636 4015636
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-8) - 4018477 4018477
Show more